Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente EUROPEAN JOURNAL OF CANCER

Tipo Año Título Fuente
Artículo2023A global collaboRAtive study of CIC-rearranged, BCOR::CCNB3-rearranged and other ultra-rare unclassified undifferentiated small round cell sarcomas (GRACefUl)EUROPEAN JOURNAL OF CANCER
Revisión2023European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023EUROPEAN JOURNAL OF CANCER
Artículo2023European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment–Update 2023EUROPEAN JOURNAL OF CANCER
Artículo2023European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma. Part 1: Diagnostics and prevention–Update 2023EUROPEAN JOURNAL OF CANCER
Artículo2022Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteriaEUROPEAN JOURNAL OF CANCER
Artículo2022Adjuvant pembrolizumab versus placebo in resected high-risk stage II melanoma: health-related quality of life from the randomized phase 3 KEYNOTE-716 studyEUROPEAN JOURNAL OF CANCER
Revisión2022Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline – Update 2022EUROPEAN JOURNAL OF CANCER
Revisión2022European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics: Update 2022EUROPEAN JOURNAL OF CANCER
Revisión2022European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2022EUROPEAN JOURNAL OF CANCER
Artículo2022Randomized phase II study of fulvestrant plus palbociclib or placebo in endocrine-sensitive, hormone receptor-positive/HER2–advanced breast cancer: GEICAM/2014–12 (FLIPPER)EUROPEAN JOURNAL OF CANCER
Artículo2020European consensus-based interdisciplinary guideline for melanoma. Part 1: Diagnostics - Update 2019EUROPEAN JOURNAL OF CANCER
Artículo2020European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment - Update 2019EUROPEAN JOURNAL OF CANCER
Artículo2020European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and preventionEUROPEAN JOURNAL OF CANCER
Artículo2020European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. TreatmentEUROPEAN JOURNAL OF CANCER
Artículo2018Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countriesEUROPEAN JOURNAL OF CANCER
Artículo2017More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatmentsEUROPEAN JOURNAL OF CANCER
Revisión2017What do we need to make circulating tumour DNA (ctDNA) a routine diagnostic test in lung cancer?EUROPEAN JOURNAL OF CANCER
Artículo2016Gene expression test for the non-invasive diagnosis of bladder cancer: a prospective, blinded, international and multicenter validation studyEUROPEAN JOURNAL OF CANCER
Resumen congreso2016Inhibition of neuroblastoma growth by the thiadiazolidinone compound TDZD-8EUROPEAN JOURNAL OF CANCER
Resumen congreso2016Loss of viability correlates with altered organ homeostasis in the GI tract of adult, Sos1/2-depleted miceEUROPEAN JOURNAL OF CANCER
Resumen congreso2016Neural crest derived progenitors give rise to tumor stroma and contribute to aggressiveness in high-risk neuroblastomaEUROPEAN JOURNAL OF CANCER
Resumen congreso2016Sos1 disruption increases mitochondrial oxidative stress in primary MEFsEUROPEAN JOURNAL OF CANCER
Resumen congreso2016Targeting Ewing Sarcoma cells and the tumor microenvironment with OMTX003 anti-endoglin monoclonal antibodiesEUROPEAN JOURNAL OF CANCER
Resumen congreso2015Follicular lymphoma and clinical characteristics of histologic transformationEUROPEAN JOURNAL OF CANCER
Resumen congreso2015Impact of baseline genetic heterogeneities on progression-free survival (PFS) in patients (pts) with advanced BRAFV600-mutated melanoma treated with cobimetinib (COBI) plus vemurafenib (VEM) in the phase 3 coBRIM studyEUROPEAN JOURNAL OF CANCER
Artículo2015Stratification of resectable lung adenocarcinoma by molecular and pathological risk estimatorsEUROPEAN JOURNAL OF CANCER
Resumen congreso2015Survival analysis of follicular lymphoma in a national registry from the spanish oncology lymphoma groupEUROPEAN JOURNAL OF CANCER
Resumen congreso2014Molecular characterization through massive parallel sequencing unveils clues regarding origin of undifferentiated endometrial carcinomasEUROPEAN JOURNAL OF CANCER
Artículo2013A single mutation in Securin induces chromosomal instability and enhances cell invasionEUROPEAN JOURNAL OF CANCER
Artículo2013Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: Results of the SIOPEN studyEUROPEAN JOURNAL OF CANCER
Resumen congreso2012Caveolin-1 Promotes Angiogenesis in Ewing's Sarcoma Through EphA2 SignalingEUROPEAN JOURNAL OF CANCER
Resumen congreso2012Effect of son of sevenless proteins depletion in mouse embryonic fibroblastsEUROPEAN JOURNAL OF CANCER
Ponencia2012Effectiveness of Single-Photon Emission Computed Tomography (spect-spect/ct) in the Staging of Breast Cancer PatientsEUROPEAN JOURNAL OF CANCER
Resumen congreso2012Immunophenotype and CD99 Expression Patterns of Human Mesenchymal Stem Cells and Their Implication in Ewing Sarcoma Genesis, Biology and TreatmentEUROPEAN JOURNAL OF CANCER
Artículo1999Carbonyl reductase and NADPH cytochrome P450 reductase activities in human tumoral versus normal tissuesEUROPEAN JOURNAL OF CANCER
Ponencia1995Effect of paclitaxel on the uptake of ciprofloxacin and ofloxacin by human neutrophilsEUROPEAN JOURNAL OF CANCER